Machine Learning for the Biochemical Genetics Laboratory.
Machine Learning for the Biochemical Genetics Laboratory.
复制标题
DOI:
10.1093/clinchem/hvaa168
复制
发表时间:
2020-09-01
影响因子:
9.3
通讯作者:
Master SR
中科院分区:
文献类型:
--
作者:
Ganetzky RD;Master SR
Machine learning has emerged as an indispensable part of modern data analysis, particularly for classifying samples based on complex sets of variables. In the realm of clinical diagnostics, it has been successfully utilized for applications ranging from identifying abnormal areas of tissue on a scanned slide image, through predicting disease progression based on laboratory results. Briefly,“machine learning”(which is a subset of artificial intelligence) begins with a data set of samples with known labels (in this case, disease diagnoses). A variety of algorithms are then used to “train” a classifier (based on this original “training set”) that will predict the appropriate diagnosis in a new, unknown sample that has not been previously analyzed. By providing computational “expertise” in analyzing a complex laboratory data set, a validated machine learning classifier can serve as a valuable aid for the clinical laboratory professional in providing interpretive or diagnostic guidance to a front-line clinician. Plasma amino acid profiling is one of the most important tests for diagnosing inborn errors of metabolism. Interpretation of an amino acid profile can be straightforward, such as in diagnosing phenylketonuria from increased phenylalanine; however, in other cases, subtle nuances may be the only diagnostic clue. The interconnectedness of amino acid concentrations is difficult to quantify for diagnostic purposes. Although studies have been done to define diagnostic ratios between two related amino acids (1), this has only been explored in the most common disorders of amino acid metabolism, and reference ranges for most of these ratios do not exist. Accurate and rapid diagnosis from amino acid concentrations is essential for providing life-saving therapies, for example, in urea cycle defects. Currently, establishing a diagnosis from amino acids requires manual review and clinical interpretation by a clinical chemist or clinical biochemical geneticist. Given the nuanced variations involved, this interpretation may rely entirely on an experienced gestalt developed by considering the full pattern of amino acid concentrations. There is a limited trained workforce to provide these interpretations. Even in skilled hands, determining whether a slight variation represents a hypomorphic form of an inborn error of metabolism or benign variation due to dietary intake, drug use, or secondary variation due to liver or renal dysfunction is a challenge. Therefore, this panel is ripe for application of a machine learning approach.Previous research on computational support to improve the clinical sensitivity and specificity of amino acid analysis has largely been within the context of newborn screening. Limited amino acid quantification is an integral part of the newborn screen. However, the challenge of newborn screening amino acids is much more circumscribed. Only a subset of amino acids is measured in newborn screening, and the diagnostic set is constrained to a small number of disorders that are part of the newborn screening program. Within this space, computational postanalytical tools to determine relationships among analytes, trained on known samples, have been utilized for several years (2). More recently, a random forest-based machine learning approach has been successfully applied to newborn screening, including the amino acid disorder ornithine transcarbamylase deficiency (3). In this issue of Clinical Chemistry, Wilkes et al. present a method to apply machine learning to automate the interpretation of a full plasma amino acid profile (4). In contrast to amino acids analyzed during newborn screening, a full amino acid profile measures at least 22 amino acids and can be used to …
登录
查看更多内容
影响因子:
3.5
作者:
Peng, Gang;Tang, Yishuo;Scharfe, Curt
通讯作者:
Scharfe, Curt
DOI:
10.1038/gim.2014.62
发表时间:
2014-12
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
通讯作者:
--
影响因子:
9.3
作者:
Wilkes, Edmund H.;Emmett, Erin;Carling, Rachel S.
通讯作者:
Carling, Rachel S.
DOI:
10.1007/8904_2012_186
发表时间:
2013-01-01
期刊:
JIMD REPORTS - CASE AND RESEARCH REPORTS, 2012/6
影响因子:
--
作者:
Rodney, S.;Boneh, A.
通讯作者:
Boneh, A.